Evidence map›Paper›PMID 40678729›Full record

ReviewFrontiers in pharmacology2025

Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome.

Zhan Li, Yingqi Liu, Wei Ding, Yue Liu, Wang Li, Shanshan Guan, Xianjun Liu, Guizhen Wang, Qiong Liu, Chunwa Jiang and 4 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zhan LiSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Yingqi LiuSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Wei DingSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Yue LiuSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Wang LiEngineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun, China.
Shanshan GuanSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Xianjun LiuSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Guizhen WangSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Qiong LiuSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Chunwa JiangSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Xinli PengSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Hao LiSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Zhandong LiSchool of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.
Jing LiSchool of Computer Science, Baicheng Normal University, Baicheng, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After recovering from severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2) acute infection, some patients with corona virus disease 2019 (COVID-19) still are affected by post-acute COVID-19 syndrome (PACS). Traditional Chinese medicine (TCM) has played an important role in the recovery period of COVID-19. As a unique type of Chinese botanical drugs, foods with property of food and medicine homology (FMH) has the dual characteristics of drug and food, which has advantages over usual drugs in safety and daily application. This review analyzed a total of 290 peer-reviewed publications on the progress of dozens of formulas and single botanical drugs, which were systematically collected from the electronic scientific databases, including PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI), as well as other literature sources, such as classic Chinese medicine books. The symptoms of PACS and the advancements in the application of FMH foods in PACS intervention are summarized, and the challenges in the regulatory characteristics and food safety are further discussed. It is expected that the application of FMH foods would bring new opportunity for the treatment and daily intervention of PACS, and this review provides a foundation for the development of PACS intervention foods.

Indexed as

food and medicine homologyfood developmentfood interventionfood safetypost-acute COVID-19 syndrome

Identifiers

PMID40678729
PMCPMC12269510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.